FDA approves Gamifant ® (emapalumab-lzsg) as first-ever treatment for adults and children with Macrophage Activation Syndrome in Still's disease
FDA approves Gamifant ® (emapalumab-lzsg) as first-ever treatment for adults and children with Macrophage Activation Syndrome in Still's disease
TodayHeadline is a dynamic news website dedicated to delivering up-to-date and comprehensive news coverage from around the globe.
© 2024 Todayheadline.co